Michael M. Buchman

Michael Buchman has more than 20 years of experience, primarily litigating antitrust, consumer protection and privacy class actions in trial and appellate courts.


Michael has a diverse antitrust background, having represented as lead or co-lead counsel a variety of plaintiff clients, from Fortune 500 companies to individual consumers, in complex cases covering matters such as restraint of trade, price-fixing, generic drug antitrust issues and anticompetitive “reverse payment” agreements between brand name pharmaceutical companies and generic companies. Michael leads Motley Rice’s antitrust team.

Michael represented the largest retailer class representative in the $6.2 billion* case In re Payment Card Interchange Fee and Merchant Discount Antitrust Litigation, MDL 1720.* He has also represented consumers, union health and welfare plans, and health insurers in “generic drug” litigation, including serving as interim co-lead counsel for end-payor multidistrict litigation for 20 years, including representing  clients as lead, co-lead or liaison counsel in generic drug litigation cases: 

Motley Rice cases:
  • In re Loestrin Antitrust Litigation ($62.5 million settlement in 2020 pending final approval)*
  • In re Aggrenox Antitrust Litigation ($54 million settlement in 2018)* 
  • In re Solodyn Antitrust Litigation ($43 million settlement in 2018)* 
Prior to Motley Rice:
  • In re Wellbutrin SR Antitrust Litigation ($21.5million settlement in 2013)*
  • In re Flonase Antitrust Litigation ($46 million settlement in 2012)* 
  • In re Metoprolol Succinate End-Payor Antitrust Litigation ($21 million settlement in 2011)* 
  • In re Relafen Antitrust Litigation ($75 million settlement in 2004)*
  • In re Augmentin Antitrust Litigation ($29 million settlement in 2004)* 
  • In re Buspirone Antitrust Litigation ($90 million settlement in 2003)*  

Additional cases he’s actively involved in include In re Actos Antitrust Litigation, In re Effexor Antitrust Litigation, In re Lipitor Antitrust Litigation, In re Niaspan Antitrust Litigation, In re Suboxone Antitrust Litigation, and In re Zetia Antitrust Litigation. 

He also has experience litigating a large aviation antitrust matter, as well as aviation crash, emergency evacuation and other aviation cases in federal and state court.

Prior to joining Motley Rice, Michael served as an Assistant Attorney General in the New York State Attorney General’s Office, Antitrust Bureau. He was also a managing partner of the antitrust department at a New York-based class action law firm. He played an active role in resolving two of the largest U.S. multi-billion dollar antitrust settlements since the Sherman Act was enacted, In re NASDAQ Market-Makers Antitrust Litigation and In re Visa Check/Mastermoney Antitrust Litigation, as well as litigated numerous multi-million dollar antitrust cases. 

Michael completed the intensive two-week National Institute for Trial Advocacy National Trial Training program in Boulder, Colo., in 2002. An avid writer, he has authored and co-authored articles on procedure and competition law, including a Task Force on Dealer Terminations for The Association of the Bar of the City of New York, Committee on Antitrust and Trade Regulation, entitled Dealer Termination in New York dated June 1,1998 and What's in a Name - the Diversity Death-Knell for Underwriters of Lloyd's of London and their Names; Humm v. Lombard World Trade, Inc., Vol. 4, Issue 10 International Insurance Law Review 314 (1996).

Michael is active in his community, serving as a member of the Flood and Erosion Committee for the Town of Westport, Ct., and as pro bono counsel in actions involving the misappropriation of perpetual care monies. He has also coached youth ice hockey teams at Chelsea Piers in New York City.

* Prior results do not guarantee a similar outcome.

Open Bio


LL.M., International Antitrust and Trade Law, Fordham University School of Law, 1993

J.D., The John Marshall Law School, 1992

B.A. cum laude, Alfred University, 1988

Licensed In

  • Connecticut
  • New York

Admitted to Practice Before

U.S. Supreme Court

U.S. Court of Appeals for the Second Circuit

U.S. District Court for the Districts of Connecticut and Southern and Eastern Districts of New York

U.S. Court of International Trade